Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constant Gillot

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Inflammation Research|March 25, 2026
Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil ModelConstant Gillot, Pauline Michaux, Jonathan Decarpentrie, et al.
Vaccines|December 23, 2022
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia SyndromeConstant Gillot, Julien Favresse, Vincent Maloteau, et al.
Clinical Chemistry and Laboratory Medicine|January 10, 2022
Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessmentJulien Favresse, Jean-Louis Bayart, Clara David, et al.
Microorganisms|April 3, 2021
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after InfectionJulien Favresse, Christine Eucher, Marc Elsen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 11, 2023
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individualsJean-Louis Bayart, Constant Gillot, Jean-Michel Dogné, et al.
Vaccines|August 28, 2021
Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the LiteratureJonathan Douxfils, Constant Gillot, Émilie De Gottal, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2023
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timingConstant Gillot, Jean-Louis Bayart, Mélanie Closset, et al.
Advanced Healthcare Materials|April 16, 2026
Device-Induced Thrombosis in Blood-Contacting Medical Devices: Mechanisms and Emerging Prevention StrategiesConstant Gillot, Pauline Michaux, Jonathan Evrard, et al.
Journal of Medical Virology|January 8, 2024
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent boosterJulien Favresse, Constant Gillot, Mélanie Closset, et al.
Clinical Chemistry and Laboratory Medicine|April 20, 2023
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administrationGermain Simon, Julien Favresse, Constant Gillot, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Inflammation Research|March 25, 2026
Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil ModelConstant Gillot, Pauline Michaux, Jonathan Decarpentrie, et al.
Vaccines|December 23, 2022
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia SyndromeConstant Gillot, Julien Favresse, Vincent Maloteau, et al.
Clinical Chemistry and Laboratory Medicine|January 10, 2022
Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessmentJulien Favresse, Jean-Louis Bayart, Clara David, et al.
Microorganisms|April 3, 2021
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after InfectionJulien Favresse, Christine Eucher, Marc Elsen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 11, 2023
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individualsJean-Louis Bayart, Constant Gillot, Jean-Michel Dogné, et al.
Vaccines|August 28, 2021
Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the LiteratureJonathan Douxfils, Constant Gillot, Émilie De Gottal, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2023
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timingConstant Gillot, Jean-Louis Bayart, Mélanie Closset, et al.
Advanced Healthcare Materials|April 16, 2026
Device-Induced Thrombosis in Blood-Contacting Medical Devices: Mechanisms and Emerging Prevention StrategiesConstant Gillot, Pauline Michaux, Jonathan Evrard, et al.
Journal of Medical Virology|January 8, 2024
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent boosterJulien Favresse, Constant Gillot, Mélanie Closset, et al.
Clinical Chemistry and Laboratory Medicine|April 20, 2023
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administrationGermain Simon, Julien Favresse, Constant Gillot, et al.
Pageof 4